文献速递前列腺增生与排尿功能障碍

高危复发压力性尿失禁患者的耻骨后与经闭孔中段尿道吊带术:系统评价与Meta分析

Retropubic versus Transobturator Mid Urethral Slings in Patients at High Risk for Recurrent Stress Incontinence: A Systematic Review and Meta-Analysis.
PubMed 文献 · J Urol · 2019-06-07

本系统评价与Meta分析纳入28项研究共2607例患者,比较耻骨后与经闭孔无张力阴道吊带术在高危复发压力性尿失禁患者中的疗效与安全性。结果显示耻骨后吊带术在总体及各个亚组(肥胖、固有括约肌缺陷、盆腔器官脱垂、复发压力性尿失禁)的客观治愈率均显著优于经闭孔吊带术,主观治愈率在总体及固有括约肌缺陷和复发压力性尿失禁亚组也显著更优,而总体并发症率两组无显著差异。

要点

  • 耻骨后吊带术在总体及各个高危亚组的客观治愈率均显著优于经闭孔吊带术
  • 耻骨后吊带术的主观治愈率在总体及固有括约肌缺陷和复发压力性尿失禁亚组显著更优
  • 两组总体并发症率无显著差异(OR 1.22,95%CI 0.89-1.66,p=0.21)

核心结论

  • 在肥胖、固有括约肌缺陷、盆腔器官脱垂及中段尿道吊带术后复发压力性尿失禁患者中,耻骨后吊带术的客观和主观治愈率均优于经闭孔吊带术,且并发症率与经闭孔吊带术相当。

研究设计与样本

  • 遵循PRISMA声明的系统评价与Meta分析,纳入随机对照试验和观察性研究,比较择定组患者初次中段尿道吊带置入后耻骨后与经闭孔无张力阴道吊带术的疗效与安全性。
  • 共检索到28项研究、总计2607例患者,平均随访26.9个月,方案在PROSPERO注册(编号CRD42018102233)。

主要发现

  • 总体客观治愈率:耻骨后吊带术显著优于经闭孔吊带术(OR 3.37,95%CI 2.55-4.43,p<0.00001,I²=37%),且在各亚组中均显著更优。
  • 总体主观治愈率:耻骨后吊带术显著优于经闭孔吊带术(OR 2.01,95%CI 1.45-2.80,p<0.0001,I²=0%),在固有括约肌缺陷及中段尿道吊带术后复发压力性尿失禁患者中也显著更优。
  • 总体并发症:两组无显著差异(OR 1.22,95%CI 0.89-1.66,p=0.21,I²=0%)。

关键数值与推荐

  • 总体客观治愈率OR 3.37(95%CI 2.55-4.43,p<0.00001,I²=37%),支持耻骨后吊带术。
  • 总体主观治愈率OR 2.01(95%CI 1.45-2.80,p<0.0001,I²=0%),支持耻骨后吊带术。
  • 总体并发症OR 1.22(95%CI 0.89-1.66,p=0.21,I²=0%),两组无显著差异。

临床怎么用

  • 对于肥胖、固有括约肌缺陷、盆腔器官脱垂及中段尿道吊带术后复发压力性尿失禁患者,Meta分析显示耻骨后吊带术在治愈率上优于经闭孔吊带术且并发症率相当,原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The efficacy and safety of retropubic and transobturator tension-free vaginal tape mid urethral slings remain controversial in patients with stress urinary incontinence and risk factors for recurrence. We compared the techniques after initial mid urethral sling insertion in select groups, including patients with obesity, intrinsic sphincter deficiency, pelvic organ prolapse and recurrent stress urinary incontinence. MATERIALS AND METHODS: We used the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement to report the methods and results of the current review. Randomized controlled trials and observational studies were included. We assessed the objective and subjective cure rates, and the complication rate using the OR with the 95% CI. The protocol of the current meta-analysis was registered on PROSPERO (No. CRD42018102233). RESULTS: We retrieved 28 studies in a total of 2,607 patients to compare the efficacy and safety of retropubic vs transobturator tension-free vaginal tape in select groups (mean followup 26.9 months). Meta-analysis of the objective cure rate showed the significant superiority of retropubic compared to transobturator tension-free vaginal tape in patients overall (OR 3.37, 95% CI 2.55-4.43, p <0.00001, I2 = 37%) and in each subpopulation. The subjective cure rate of retropubic tension-free vaginal tape was also significantly superior to that of transobturator tension-free vaginal tape in in patients overall (OR 2.01, 95% CI 1.45-2.80, p <0.0001, I2 = 0%) and in those with intrinsic sphincter deficiency and recurrent stress urinary incontinence after mid urethral sling insertion. There was no significant difference in overall complications between retropubic and transobturator tension-free vaginal tape (OR 1.22, 95% CI 0.89-1.66, p = 0.21, I2 = 0%). CONCLUSIONS: The meta-analysis showed the superiority of retropubic tension-free vaginal tape over transobturator tension-free vaginal tape in terms of the objective and subjective cure rates in patients with obesity, intrinsic sphincter deficiency, pelvic organ prolapse and recurrent stress urinary incontinence after mid urethral sling insertion. Retropubic tension-free vaginal tape also has morbidity comparable to that of transobturator tension-free vaginal tape.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Kim A, Kim MS, Park YJ, et al. Retropubic versus Transobturator Mid Urethral Slings in Patients at High Risk for Recurrent Stress Incontinence: A Systematic Review and Meta-Analysis. J Urol. 2019. PMID: 30865553. doi:10.1097/JU.0000000000000222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。